Legal Representation
Attorney
Sharon R. Smith
USPTO Deadlines
Next Deadline
357 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2006-07-04)
Due Date
July 04, 2026
Grace Period Ends
January 04, 2027
Application History
48 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 4, 2025 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Nov 20, 2024 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Feb 15, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Feb 15, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Feb 15, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Apr 17, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Apr 17, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Apr 17, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Apr 17, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Apr 17, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Feb 24, 2016 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| Feb 24, 2016 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| Feb 24, 2016 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| Feb 24, 2016 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Dec 10, 2015 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
| Jul 4, 2015 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| May 30, 2012 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| May 30, 2012 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| May 30, 2012 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| May 21, 2012 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
| Jul 4, 2006 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| May 18, 2006 | REGV | O | LAW OFFICE REGISTRATION REVIEW COMPLETED |
| May 16, 2006 | ALIE | A | ASSIGNED TO LIE |
| Apr 24, 2006 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Jan 30, 2006 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Jan 30, 2006 | DPCC | D | DIVISIONAL PROCESSING COMPLETE |
| Dec 28, 2005 | IUAF | S | USE AMENDMENT FILED |
| Dec 28, 2005 | DRRR | I | DIVISIONAL REQUEST RECEIVED |
| Dec 28, 2005 | I | PAPER RECEIVED | |
| Jun 10, 2005 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jun 10, 2005 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jun 10, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 14, 2004 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Dec 8, 2004 | EXT1 | S | SOU EXTENSION 1 FILED |
| Dec 8, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 29, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 6, 2004 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 17, 2004 | NPUB | O | NOTICE OF PUBLICATION |
| Feb 5, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 8, 2003 | CFIT | O | CASE FILE IN TICRS |
| Nov 24, 2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Nov 24, 2003 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jun 30, 2003 | GNFR | O | FINAL REFUSAL E-MAILED |
| Jun 2, 2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 2, 2003 | I | PAPER RECEIVED | |
| May 16, 2003 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Nov 27, 2002 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Nov 27, 2002 | DOCK | D | ASSIGNED TO EXAMINER |
Detailed Classifications
Class 005
THERAPEUTIC, DIAGNOSTIC, AND PROPHYLACTIC PREPARATIONS, PHARMACEUTICAL PRODUCTS AND AGENTS FOR THE TREATMENT, DIAGNOSIS OR PROPHYLAXIS OF HUMAN DISEASES, DISORDERS AND CONDITIONS, NAMELY, CANCER, DISEASES, DISORDERS AND CONDITIONS OF THE HEMATOLOGICAL SYSTEMS
First Use Anywhere:
Jul 13, 2005
First Use in Commerce:
Jul 13, 2005
Class 042
Scientific research and development of preparations, agents and biotechnology for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely cancer, diabetes, arthritis, osteoporosis, bone fractures and wound healing, and diseases, disorders and conditions of the cardiovascular, hematological, neuronal and nervous systems; scientific research and development of cosmetics, sundries and nutraceuticals; providing medical and scientific information to scientists, physicians and other health care providers
First Use Anywhere:
19990500
First Use in Commerce:
19990500
Classification
International Classes
005
042